Selected research
Market Analysis & Forecast
Global Proteomics Research Services Market Analysis and Forecast 2026-2032
Market perspective
The global Proteomics Research Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Proteomics Research Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Proteomics Research Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Proteomics Research Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Proteomics Research Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Proteomics Research Services include PTM BIO, Standard Biotools, Labcorp, BostonGene, APTBIO, Cell Signaling Technology (CST), Inotiv, Bruker Spatial Biology and BGI Genomics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Proteomics Research Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Proteomics Research Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Proteomics Research Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Proteomics Research Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Proteomics Research Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Proteomics Research Services revenue, projected growth trends, production technology, application and end-user industry.
Proteomics Research Services Segment by Company
PTM BIO
Standard Biotools
Labcorp
BostonGene
APTBIO
Cell Signaling Technology (CST)
Inotiv
Bruker Spatial Biology
BGI Genomics
Biognosys
Crown Bioscience
Eurofins Scientific
Charles River Laboratories
Discovery Life Sciences
Shanghai OE Biotech
Biodesix
Novogene
OmicScouts (Momentum Biotechnologies)
Lc-Bio Technologies
Creative Proteomics
Metware Biotechnology
GENEWIZ (Azenta Life Sciences)
CDI Labs
Evotec
MS Bioworks
Shanghai Bioprofile
MtoZ-Biolabs
Shanghai Majorbio Bio-Pharm
Firalis Molecular Precision
CD Genomics
MRM Proteomics
Panome Bio
Beijing Biomarker Technologies
Sampled (Infinity Biologix)
Sinotech Genomics
Applied Biomics
Westlake Omics
Sapient Bioanalytics
RxCelerate
Vizgen
Allumiqs
VProteomics
Precision Biomarker Laboratories (PBL)
Proteome Sciences
Proteomics International
TATAA Biocenter
Cosmos Wisdom
Olink (Thermo Fisher Scientific)
SomaLogic (Illumina)
CellCarta
Proteomics Research Services Segment by Type
Standard Proteomics
Modified Proteomics
Spatial Proteomics
Blood Proteomics
Other Proteomics
Proteomics Research Services Segment by Application
Clinical Diagnostics
Drug Discovery
Others
Proteomics Research Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Proteomics Research Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Proteomics Research Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Proteomics Research Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Proteomics Research Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Proteomics Research Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Proteomics Research Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Standard Proteomics
- Modified Proteomics
- Spatial Proteomics
- Blood Proteomics
- Other Proteomics
Applications
- Clinical Diagnostics
- Drug Discovery
- Others
Companies covered
- PTM BIO
- Standard Biotools
- Labcorp
- BostonGene
- APTBIO
- Cell Signaling Technology (CST)
- Inotiv
- Bruker Spatial Biology
- BGI Genomics
- Biognosys
- Crown Bioscience
- Eurofins Scientific
- Charles River Laboratories
- Discovery Life Sciences
- Shanghai OE Biotech
- Biodesix
- Novogene
- OmicScouts (Momentum Biotechnologies)
- Lc-Bio Technologies
- Creative Proteomics
- Metware Biotechnology
- GENEWIZ (Azenta Life Sciences)
- CDI Labs
- Evotec
- MS Bioworks
- Shanghai Bioprofile
- MtoZ-Biolabs
- Shanghai Majorbio Bio-Pharm
- Firalis Molecular Precision
- CD Genomics
- MRM Proteomics
- Panome Bio
- Beijing Biomarker Technologies
- Sampled (Infinity Biologix)
- Sinotech Genomics
- Applied Biomics
- Westlake Omics
- Sapient Bioanalytics
- RxCelerate
- Vizgen
- Allumiqs
- VProteomics
- Precision Biomarker Laboratories (PBL)
- Proteome Sciences
- Proteomics International
- TATAA Biocenter
- Cosmos Wisdom
- Olink (Thermo Fisher Scientific)
- SomaLogic (Illumina)
- CellCarta
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Proteomics Research Services Market by Type
- 1.2.1 Global Proteomics Research Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Standard Proteomics
- 1.2.3 Modified Proteomics
- 1.2.4 Spatial Proteomics
- 1.2.5 Blood Proteomics
- 1.2.6 Other Proteomics
- 1.3 Proteomics Research Services Market by Application
- 1.3.1 Global Proteomics Research Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Clinical Diagnostics
- 1.3.3 Drug Discovery
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Proteomics Research Services Market Dynamics
- 2.1 Proteomics Research Services Industry Trends
- 2.2 Proteomics Research Services Industry Drivers
- 2.3 Proteomics Research Services Industry Opportunities and Challenges
- 2.4 Proteomics Research Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Proteomics Research Services Market Perspective (2021-2032)
- 3.2 Global Proteomics Research Services Growth Trends by Region
- 3.2.1 Global Proteomics Research Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Proteomics Research Services Market Size by Region (2021-2026)
- 3.2.3 Global Proteomics Research Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Proteomics Research Services Revenue by Players
- 4.1.1 Global Proteomics Research Services Revenue by Players (2021-2026)
- 4.1.2 Global Proteomics Research Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Proteomics Research Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Proteomics Research Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Proteomics Research Services Key Players Headquarters & Area Served
- 4.4 Global Proteomics Research Services Players, Product Type & Application
- 4.5 Global Proteomics Research Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Proteomics Research Services Market CR5 and HHI
- 4.6.3 2025 Proteomics Research Services Tier 1, Tier 2, and Tier 3
5 Proteomics Research Services Market Size by Type
- 5.1 Global Proteomics Research Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Proteomics Research Services Revenue by Type (2021-2032)
- 5.3 Global Proteomics Research Services Revenue Market Share by Type (2021-2032)
6 Proteomics Research Services Market Size by Application
- 6.1 Global Proteomics Research Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Proteomics Research Services Revenue by Application (2021-2032)
- 6.3 Global Proteomics Research Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 PTM BIO
- 7.1.1 PTM BIO Company Information
- 7.1.2 PTM BIO Business Overview
- 7.1.3 PTM BIO Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.1.4 PTM BIO Proteomics Research Services Product Portfolio
- 7.1.5 PTM BIO Recent Developments
- 7.2 Standard Biotools
- 7.2.1 Standard Biotools Company Information
- 7.2.2 Standard Biotools Business Overview
- 7.2.3 Standard Biotools Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.2.4 Standard Biotools Proteomics Research Services Product Portfolio
- 7.2.5 Standard Biotools Recent Developments
- 7.3 Labcorp
- 7.3.1 Labcorp Company Information
- 7.3.2 Labcorp Business Overview
- 7.3.3 Labcorp Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.3.4 Labcorp Proteomics Research Services Product Portfolio
- 7.3.5 Labcorp Recent Developments
- 7.4 BostonGene
- 7.4.1 BostonGene Company Information
- 7.4.2 BostonGene Business Overview
- 7.4.3 BostonGene Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.4.4 BostonGene Proteomics Research Services Product Portfolio
- 7.4.5 BostonGene Recent Developments
- 7.5 APTBIO
- 7.5.1 APTBIO Company Information
- 7.5.2 APTBIO Business Overview
- 7.5.3 APTBIO Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.5.4 APTBIO Proteomics Research Services Product Portfolio
- 7.5.5 APTBIO Recent Developments
- 7.6 Cell Signaling Technology (CST)
- 7.6.1 Cell Signaling Technology (CST) Company Information
- 7.6.2 Cell Signaling Technology (CST) Business Overview
- 7.6.3 Cell Signaling Technology (CST) Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.6.4 Cell Signaling Technology (CST) Proteomics Research Services Product Portfolio
- 7.6.5 Cell Signaling Technology (CST) Recent Developments
- 7.7 Inotiv
- 7.7.1 Inotiv Company Information
- 7.7.2 Inotiv Business Overview
- 7.7.3 Inotiv Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.7.4 Inotiv Proteomics Research Services Product Portfolio
- 7.7.5 Inotiv Recent Developments
- 7.8 Bruker Spatial Biology
- 7.8.1 Bruker Spatial Biology Company Information
- 7.8.2 Bruker Spatial Biology Business Overview
- 7.8.3 Bruker Spatial Biology Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.8.4 Bruker Spatial Biology Proteomics Research Services Product Portfolio
- 7.8.5 Bruker Spatial Biology Recent Developments
- 7.9 BGI Genomics
- 7.9.1 BGI Genomics Company Information
- 7.9.2 BGI Genomics Business Overview
- 7.9.3 BGI Genomics Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.9.4 BGI Genomics Proteomics Research Services Product Portfolio
- 7.9.5 BGI Genomics Recent Developments
- 7.10 Biognosys
- 7.10.1 Biognosys Company Information
- 7.10.2 Biognosys Business Overview
- 7.10.3 Biognosys Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.10.4 Biognosys Proteomics Research Services Product Portfolio
- 7.10.5 Biognosys Recent Developments
- 7.11 Crown Bioscience
- 7.11.1 Crown Bioscience Company Information
- 7.11.2 Crown Bioscience Business Overview
- 7.11.3 Crown Bioscience Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.11.4 Crown Bioscience Proteomics Research Services Product Portfolio
- 7.11.5 Crown Bioscience Recent Developments
- 7.12 Eurofins Scientific
- 7.12.1 Eurofins Scientific Company Information
- 7.12.2 Eurofins Scientific Business Overview
- 7.12.3 Eurofins Scientific Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.12.4 Eurofins Scientific Proteomics Research Services Product Portfolio
- 7.12.5 Eurofins Scientific Recent Developments
- 7.13 Charles River Laboratories
- 7.13.1 Charles River Laboratories Company Information
- 7.13.2 Charles River Laboratories Business Overview
- 7.13.3 Charles River Laboratories Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.13.4 Charles River Laboratories Proteomics Research Services Product Portfolio
- 7.13.5 Charles River Laboratories Recent Developments
- 7.14 Discovery Life Sciences
- 7.14.1 Discovery Life Sciences Company Information
- 7.14.2 Discovery Life Sciences Business Overview
- 7.14.3 Discovery Life Sciences Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.14.4 Discovery Life Sciences Proteomics Research Services Product Portfolio
- 7.14.5 Discovery Life Sciences Recent Developments
- 7.15 Shanghai OE Biotech
- 7.15.1 Shanghai OE Biotech Company Information
- 7.15.2 Shanghai OE Biotech Business Overview
- 7.15.3 Shanghai OE Biotech Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.15.4 Shanghai OE Biotech Proteomics Research Services Product Portfolio
- 7.15.5 Shanghai OE Biotech Recent Developments
- 7.16 Biodesix
- 7.16.1 Biodesix Company Information
- 7.16.2 Biodesix Business Overview
- 7.16.3 Biodesix Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.16.4 Biodesix Proteomics Research Services Product Portfolio
- 7.16.5 Biodesix Recent Developments
- 7.17 Novogene
- 7.17.1 Novogene Company Information
- 7.17.2 Novogene Business Overview
- 7.17.3 Novogene Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.17.4 Novogene Proteomics Research Services Product Portfolio
- 7.17.5 Novogene Recent Developments
- 7.18 OmicScouts (Momentum Biotechnologies)
- 7.18.1 OmicScouts (Momentum Biotechnologies) Company Information
- 7.18.2 OmicScouts (Momentum Biotechnologies) Business Overview
- 7.18.3 OmicScouts (Momentum Biotechnologies) Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.18.4 OmicScouts (Momentum Biotechnologies) Proteomics Research Services Product Portfolio
- 7.18.5 OmicScouts (Momentum Biotechnologies) Recent Developments
- 7.19 Lc-Bio Technologies
- 7.19.1 Lc-Bio Technologies Company Information
- 7.19.2 Lc-Bio Technologies Business Overview
- 7.19.3 Lc-Bio Technologies Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.19.4 Lc-Bio Technologies Proteomics Research Services Product Portfolio
- 7.19.5 Lc-Bio Technologies Recent Developments
- 7.20 Creative Proteomics
- 7.20.1 Creative Proteomics Company Information
- 7.20.2 Creative Proteomics Business Overview
- 7.20.3 Creative Proteomics Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.20.4 Creative Proteomics Proteomics Research Services Product Portfolio
- 7.20.5 Creative Proteomics Recent Developments
- 7.21 Metware Biotechnology
- 7.21.1 Metware Biotechnology Company Information
- 7.21.2 Metware Biotechnology Business Overview
- 7.21.3 Metware Biotechnology Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.21.4 Metware Biotechnology Proteomics Research Services Product Portfolio
- 7.21.5 Metware Biotechnology Recent Developments
- 7.22 GENEWIZ (Azenta Life Sciences)
- 7.22.1 GENEWIZ (Azenta Life Sciences) Company Information
- 7.22.2 GENEWIZ (Azenta Life Sciences) Business Overview
- 7.22.3 GENEWIZ (Azenta Life Sciences) Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.22.4 GENEWIZ (Azenta Life Sciences) Proteomics Research Services Product Portfolio
- 7.22.5 GENEWIZ (Azenta Life Sciences) Recent Developments
- 7.23 CDI Labs
- 7.23.1 CDI Labs Company Information
- 7.23.2 CDI Labs Business Overview
- 7.23.3 CDI Labs Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.23.4 CDI Labs Proteomics Research Services Product Portfolio
- 7.23.5 CDI Labs Recent Developments
- 7.24 Evotec
- 7.24.1 Evotec Company Information
- 7.24.2 Evotec Business Overview
- 7.24.3 Evotec Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.24.4 Evotec Proteomics Research Services Product Portfolio
- 7.24.5 Evotec Recent Developments
- 7.25 MS Bioworks
- 7.25.1 MS Bioworks Company Information
- 7.25.2 MS Bioworks Business Overview
- 7.25.3 MS Bioworks Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.25.4 MS Bioworks Proteomics Research Services Product Portfolio
- 7.25.5 MS Bioworks Recent Developments
- 7.26 Shanghai Bioprofile
- 7.26.1 Shanghai Bioprofile Company Information
- 7.26.2 Shanghai Bioprofile Business Overview
- 7.26.3 Shanghai Bioprofile Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.26.4 Shanghai Bioprofile Proteomics Research Services Product Portfolio
- 7.26.5 Shanghai Bioprofile Recent Developments
- 7.27 MtoZ-Biolabs
- 7.27.1 MtoZ-Biolabs Company Information
- 7.27.2 MtoZ-Biolabs Business Overview
- 7.27.3 MtoZ-Biolabs Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.27.4 MtoZ-Biolabs Proteomics Research Services Product Portfolio
- 7.27.5 MtoZ-Biolabs Recent Developments
- 7.28 Shanghai Majorbio Bio-Pharm
- 7.28.1 Shanghai Majorbio Bio-Pharm Company Information
- 7.28.2 Shanghai Majorbio Bio-Pharm Business Overview
- 7.28.3 Shanghai Majorbio Bio-Pharm Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.28.4 Shanghai Majorbio Bio-Pharm Proteomics Research Services Product Portfolio
- 7.28.5 Shanghai Majorbio Bio-Pharm Recent Developments
- 7.29 Firalis Molecular Precision
- 7.29.1 Firalis Molecular Precision Company Information
- 7.29.2 Firalis Molecular Precision Business Overview
- 7.29.3 Firalis Molecular Precision Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.29.4 Firalis Molecular Precision Proteomics Research Services Product Portfolio
- 7.29.5 Firalis Molecular Precision Recent Developments
- 7.30 CD Genomics
- 7.30.1 CD Genomics Company Information
- 7.30.2 CD Genomics Business Overview
- 7.30.3 CD Genomics Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.30.4 CD Genomics Proteomics Research Services Product Portfolio
- 7.30.5 CD Genomics Recent Developments
- 7.31 MRM Proteomics
- 7.31.1 MRM Proteomics Company Information
- 7.31.2 MRM Proteomics Business Overview
- 7.31.3 MRM Proteomics Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.31.4 MRM Proteomics Proteomics Research Services Product Portfolio
- 7.31.5 MRM Proteomics Recent Developments
- 7.32 Panome Bio
- 7.32.1 Panome Bio Company Information
- 7.32.2 Panome Bio Business Overview
- 7.32.3 Panome Bio Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.32.4 Panome Bio Proteomics Research Services Product Portfolio
- 7.32.5 Panome Bio Recent Developments
- 7.33 Beijing Biomarker Technologies
- 7.33.1 Beijing Biomarker Technologies Company Information
- 7.33.2 Beijing Biomarker Technologies Business Overview
- 7.33.3 Beijing Biomarker Technologies Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.33.4 Beijing Biomarker Technologies Proteomics Research Services Product Portfolio
- 7.33.5 Beijing Biomarker Technologies Recent Developments
- 7.34 Sampled (Infinity Biologix)
- 7.34.1 Sampled (Infinity Biologix) Company Information
- 7.34.2 Sampled (Infinity Biologix) Business Overview
- 7.34.3 Sampled (Infinity Biologix) Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.34.4 Sampled (Infinity Biologix) Proteomics Research Services Product Portfolio
- 7.34.5 Sampled (Infinity Biologix) Recent Developments
- 7.35 Sinotech Genomics
- 7.35.1 Sinotech Genomics Company Information
- 7.35.2 Sinotech Genomics Business Overview
- 7.35.3 Sinotech Genomics Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.35.4 Sinotech Genomics Proteomics Research Services Product Portfolio
- 7.35.5 Sinotech Genomics Recent Developments
- 7.36 Applied Biomics
- 7.36.1 Applied Biomics Company Information
- 7.36.2 Applied Biomics Business Overview
- 7.36.3 Applied Biomics Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.36.4 Applied Biomics Proteomics Research Services Product Portfolio
- 7.36.5 Applied Biomics Recent Developments
- 7.37 Westlake Omics
- 7.37.1 Westlake Omics Company Information
- 7.37.2 Westlake Omics Business Overview
- 7.37.3 Westlake Omics Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.37.4 Westlake Omics Proteomics Research Services Product Portfolio
- 7.37.5 Westlake Omics Recent Developments
- 7.38 Sapient Bioanalytics
- 7.38.1 Sapient Bioanalytics Company Information
- 7.38.2 Sapient Bioanalytics Business Overview
- 7.38.3 Sapient Bioanalytics Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.38.4 Sapient Bioanalytics Proteomics Research Services Product Portfolio
- 7.38.5 Sapient Bioanalytics Recent Developments
- 7.39 RxCelerate
- 7.39.1 RxCelerate Company Information
- 7.39.2 RxCelerate Business Overview
- 7.39.3 RxCelerate Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.39.4 RxCelerate Proteomics Research Services Product Portfolio
- 7.39.5 RxCelerate Recent Developments
- 7.40 Vizgen
- 7.40.1 Vizgen Company Information
- 7.40.2 Vizgen Business Overview
- 7.40.3 Vizgen Proteomics Research Services Revenue and Gross Margin (2021-2026)
- 7.40.4 Vizgen Proteomics Research Services Product Portfolio
- 7.40.5 Vizgen Recent Developments
- 7.41 Allumiqs
- 7.42 VProteomics
- 7.43 Precision Biomarker Laboratories (PBL)
- 7.44 Proteome Sciences
- 7.45 Proteomics International
- 7.46 TATAA Biocenter
- 7.47 Cosmos Wisdom
- 7.48 Olink (Thermo Fisher Scientific)
- 7.49 SomaLogic (Illumina)
- 7.50 CellCarta
8 North America
- 8.1 North America Proteomics Research Services Revenue (2021-2032)
- 8.2 North America Proteomics Research Services Revenue by Type (2021-2032)
- 8.2.1 North America Proteomics Research Services Revenue by Type (2021-2026)
- 8.2.2 North America Proteomics Research Services Revenue by Type (2027-2032)
- 8.3 North America Proteomics Research Services Revenue Share by Type (2021-2032)
- 8.4 North America Proteomics Research Services Revenue by Application (2021-2032)
- 8.4.1 North America Proteomics Research Services Revenue by Application (2021-2026)
- 8.4.2 North America Proteomics Research Services Revenue by Application (2027-2032)
- 8.5 North America Proteomics Research Services Revenue Share by Application (2021-2032)
- 8.6 North America Proteomics Research Services Revenue by Country
- 8.6.1 North America Proteomics Research Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Proteomics Research Services Revenue by Country (2021-2026)
- 8.6.3 North America Proteomics Research Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Proteomics Research Services Revenue (2021-2032)
- 9.2 Europe Proteomics Research Services Revenue by Type (2021-2032)
- 9.2.1 Europe Proteomics Research Services Revenue by Type (2021-2026)
- 9.2.2 Europe Proteomics Research Services Revenue by Type (2027-2032)
- 9.3 Europe Proteomics Research Services Revenue Share by Type (2021-2032)
- 9.4 Europe Proteomics Research Services Revenue by Application (2021-2032)
- 9.4.1 Europe Proteomics Research Services Revenue by Application (2021-2026)
- 9.4.2 Europe Proteomics Research Services Revenue by Application (2027-2032)
- 9.5 Europe Proteomics Research Services Revenue Share by Application (2021-2032)
- 9.6 Europe Proteomics Research Services Revenue by Country
- 9.6.1 Europe Proteomics Research Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Proteomics Research Services Revenue by Country (2021-2026)
- 9.6.3 Europe Proteomics Research Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Proteomics Research Services Revenue (2021-2032)
- 10.2 China Proteomics Research Services Revenue by Type (2021-2032)
- 10.2.1 China Proteomics Research Services Revenue by Type (2021-2026)
- 10.2.2 China Proteomics Research Services Revenue by Type (2027-2032)
- 10.3 China Proteomics Research Services Revenue Share by Type (2021-2032)
- 10.4 China Proteomics Research Services Revenue by Application (2021-2032)
- 10.4.1 China Proteomics Research Services Revenue by Application (2021-2026)
- 10.4.2 China Proteomics Research Services Revenue by Application (2027-2032)
- 10.5 China Proteomics Research Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Proteomics Research Services Revenue (2021-2032)
- 11.2 Asia Proteomics Research Services Revenue by Type (2021-2032)
- 11.2.1 Asia Proteomics Research Services Revenue by Type (2021-2026)
- 11.2.2 Asia Proteomics Research Services Revenue by Type (2027-2032)
- 11.3 Asia Proteomics Research Services Revenue Share by Type (2021-2032)
- 11.4 Asia Proteomics Research Services Revenue by Application (2021-2032)
- 11.4.1 Asia Proteomics Research Services Revenue by Application (2021-2026)
- 11.4.2 Asia Proteomics Research Services Revenue by Application (2027-2032)
- 11.5 Asia Proteomics Research Services Revenue Share by Application (2021-2032)
- 11.6 Asia Proteomics Research Services Revenue by Country
- 11.6.1 Asia Proteomics Research Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Proteomics Research Services Revenue by Country (2021-2026)
- 11.6.3 Asia Proteomics Research Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Proteomics Research Services Revenue (2021-2032)
- 12.2 SAMEA Proteomics Research Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Proteomics Research Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Proteomics Research Services Revenue by Type (2027-2032)
- 12.3 SAMEA Proteomics Research Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Proteomics Research Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Proteomics Research Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Proteomics Research Services Revenue by Application (2027-2032)
- 12.5 SAMEA Proteomics Research Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Proteomics Research Services Revenue by Country
- 12.6.1 SAMEA Proteomics Research Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Proteomics Research Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Proteomics Research Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst